Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-02-28 Sale |
2022-03-02 3:20 pm |
Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon Chief Scientific Officer |
12,452 | $10.24 | $127,477 | 1,638,888 (Indirect Direct) |
View |
| 2022-02-17 Sale |
2022-02-22 4:15 pm |
Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon Chief Scientific Officer |
18,167 | $12.12 | $220,246 | 1,603,340 (Indirect Direct) |
View |
| 2022-02-07 Sale |
2022-02-09 5:22 pm |
Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon Chief Scientific Officer |
13,471 | $9.862 | $132,851 | 1,621,507 (Indirect Direct) |
View |
| 2021-03-18 Sale |
2021-03-23 07:50 am |
Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon President & CSO |
4,000 | $12.39 | $49,553 | 1,634,978 (Indirect Direct) |
View |
| 2021-02-18 Sale |
2021-02-22 8:10 pm |
Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon President & CSO |
18,990 | $14.83 | $281,644 | 1,351,578 (Indirect Direct) |
View |
| 2021-02-11 Sale |
2021-02-17 6:45 pm |
Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon President & CSO |
13,243 | $15.52 | $205,518 | 1,457,768 (Indirect Direct) |
View |
| 2020-10-12 Sale |
2020-10-14 5:54 pm |
Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon President & CSO |
7,500 | $14.89 | $111,683 | 1,311,611 (Indirect Direct) |
View |
| 2020-08-17 Sale |
2020-08-18 6:05 pm |
Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon President & CSO |
1,477 | $15 | $22,155 | 1,317,687 (Indirect Direct) |
View |
| 2020-07-15 Sale |
2020-07-17 4:24 pm |
Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon President & CSO |
7,500 | $19.43 | $145,723 | 1,313,035 (Indirect Direct) |
View |
| 2020-07-09 Sale |
2020-07-13 6:43 pm |
Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon President & CSO |
15,000 | $19.27 | $289,026 | 2,022,975 (Indirect Direct) |
View |
| 2020-06-22 Sale |
2020-06-24 4:05 pm |
Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon President & CSO |
7,500 | $20 | $150,000 | 1,320,535 (Indirect Direct) |
View |
| 2020-06-15 Sale |
2020-06-17 4:05 pm |
Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon President & CSO |
7,500 | $16.37 | $122,779 | 1,328,035 (Indirect Direct) |
View |
| 2020-06-09 Sale |
2020-06-11 4:36 pm |
Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon President & CSO |
15,000 | $18.31 | $274,690 | 2,037,975 (Indirect Direct) |
View |
| 2020-05-15 Sale |
2020-05-19 5:34 pm |
Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon President & CSO |
15,000 | $19.32 | $289,841 | 1,319,825 (Indirect Direct) |
View |
| 2020-05-07 Sale |
2020-05-11 4:22 pm |
Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon President & CSO |
15,000 | $19.63 | $294,414 | 2,052,975 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-20 Option Award |
2024-06-24 5:27 pm |
N/A 2034-06-19 |
Acrivon Therapeutics Inc. | ACRV | Shacham Sharon Director |
20,275 | $0 | 20,275 (Direct) |
View |
| 2022-11-14 Option Award |
2022-11-16 7:28 pm |
N/A 2032-11-13 |
Acrivon Therapeutics Inc. | ACRV | Shacham Sharon Director |
35,235 | $0 | 35,235 (Direct) |
View |
| 2022-03-29 Option Award |
2022-03-31 4:17 pm |
N/A 2032-03-28 |
Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon Chief Scientific Officer |
150,000 | $0 | 1,761,888 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-02 3:20 pm |
N/A 2032-02-27 |
Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon Chief Scientific Officer |
48,000 | $0 | 1,638,888 (Indirect) |
View |
| 2021-02-25 Option Award |
2021-03-01 8:09 pm |
N/A 2031-02-24 |
Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon President & CSO |
364,200 | $0 | 1,945,978 (Direct) |
View |
| 2021-02-15 Exercise |
2021-02-17 6:45 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon President & CSO |
43,600 | $0 | 1,457,768 (Direct) |
View |
| 2021-02-05 Exercise |
2021-02-09 8:30 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon President & CSO |
28,600 | $0 | 1,426,011 (Direct) |
View |
| 2020-10-12 Exercise |
2020-10-14 5:54 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon President & CSO |
7,500 | $0.033 | 1,311,611 (Direct) |
View |
| 2020-10-12 Exercise |
2020-10-14 5:54 pm |
N/A 2020-10-31 |
Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon President & CSO |
7,500 | $0 | 1,311,611 (Direct) |
View |
| 2020-08-17 Exercise |
2020-08-18 6:05 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon President & CSO |
1,477 | $0.033 | 1,317,687 (Direct) |
View |
| 2020-08-17 Exercise |
2020-08-18 6:05 pm |
N/A 2020-10-31 |
Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon President & CSO |
1,477 | $0 | 1,317,687 (Direct) |
View |
| 2020-07-15 Exercise |
2020-07-17 4:24 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon President & CSO |
7,500 | $0.033 | 1,313,035 (Direct) |
View |
| 2020-07-15 Exercise |
2020-07-17 4:24 pm |
N/A 2020-10-31 |
Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon President & CSO |
7,500 | $0 | 1,313,035 (Direct) |
View |
| 2020-07-09 Exercise |
2020-07-13 6:43 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon President & CSO |
15,000 | $4.752 | 2,022,975 (Direct) |
View |
| 2020-07-09 Exercise |
2020-07-13 6:43 pm |
N/A 2023-09-02 |
Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon President & CSO |
15,000 | $0 | 2,022,975 (Direct) |
View |
| 2020-06-22 Exercise |
2020-06-24 4:05 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon President & CSO |
7,500 | $0.033 | 1,320,535 (Direct) |
View |
| 2020-06-22 Exercise |
2020-06-24 4:05 pm |
N/A 2020-10-31 |
Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon President & CSO |
7,500 | $0 | 1,320,535 (Direct) |
View |
| 2020-06-15 Exercise |
2020-06-17 4:05 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon President & CSO |
7,500 | $0.033 | 1,328,035 (Direct) |
View |
| 2020-06-15 Exercise |
2020-06-17 4:05 pm |
N/A 2020-10-31 |
Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon President & CSO |
7,500 | $0 | 1,328,035 (Direct) |
View |
| 2020-06-09 Exercise |
2020-06-11 4:36 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon President & CSO |
15,000 | $4.752 | 2,037,975 (Direct) |
View |
| 2020-06-09 Exercise |
2020-06-11 4:36 pm |
N/A 2023-09-02 |
Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon President & CSO |
15,000 | $0 | 2,037,975 (Direct) |
View |
| 2020-05-15 Exercise |
2020-05-19 5:34 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon President & CSO |
15,000 | $0.033 | 1,319,825 (Direct) |
View |
| 2020-05-15 Exercise |
2020-05-19 5:34 pm |
N/A 2020-10-21 |
Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon President & CSO |
15,000 | $0 | 1,319,825 (Direct) |
View |
| 2020-05-07 Exercise |
2020-05-11 4:22 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon President & CSO |
7,500 | $4.752 | 2,052,975 (Direct) |
View |
| 2020-05-07 Exercise |
2020-05-11 4:22 pm |
N/A 2023-09-02 |
Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon President & CSO |
15,000 | $0 | 2,052,975 (Direct) |
View |